NCT00004258View on ClinicalTrials.gov

EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 31, 1999

Primary Completion Date

August 31, 2001

Study Completion Date

September 30, 2001

Conditions
Chronic Myeloproliferative DisordersLeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic SyndromesPrecancerous/Nonmalignant ConditionSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

cilengitide

dose escalation of cilengitide

Trial Locations (1)

46202-5265

Indiana University Cancer Center, Indianapolis

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Indiana University School of Medicine

OTHER

NCT00004258 - EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer | Biotech Hunter | Biotech Hunter